Sort
34,240 grants matching “atherosclerosis”
CD40 monocyte in chronic kidney disease
$714,044Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2020 · DK
Protein Arginine Methylation in Vascular Smooth Muscle Cell Phenotypic Modulation and Calcification
$714,036Yabing Chen · University Of Alabama At Birmingham · R01 · FY2023 · HL
Comprehensive Magnetic Resonance in PAD
$713,974Christopher M Kramer · University Of Virginia · R01 · FY2019 · HL
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
$713,949Ryan Eugene Temel · University Of Kentucky · R01 · FY2016 · HL
Cardiac photon counting CT and its application in studying interactions between Alzheimer's and heart disease
$713,940Cristian T Badea · Duke University · R01 · FY2025 · AG
ARTERIAL ENDOTHELIAL FUNCTION--AN EPIDEMIOLOGIC STUDY
$713,907University Of Iowa · R37 · FY2003 · HL
Personalized lesion modification optimizes atherosclerosis intervention
$713,868Elazer R Edelman · Massachusetts Institute Of Technology · R01 · FY2022 · HL
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation
$713,853David Y Hui · University Of Cincinnati · R01 · FY2014 · HL
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery Disease
$713,852Brian H Annex · University Of Virginia · R01 · FY2019 · HL
Novel peptide reagents for imaging damage to collagen structure in histopathology and in vivo
$713,771Lucas Louis Bennink · 3helix, Inc. · R44 · FY2020 · OD
Exercise pressor reflex in peripheral artery disease: beneficial effects of heating and mechanisms
$713,673Jianhua Li · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · HL
Pathways to cardiovascular disease prevention and impact of specialty referral in under-represented racial/ethnic minorities with HIV
$713,530Gerald Samuel Bloomfield · Duke University · R01 · FY2019 · MD
Lipoprotein (a) Modification of the Impact of HIV Infection on Atherosclerotic Cardiovascular Disease
$713,464Thorsten M Leucker · Johns Hopkins University · R01 · FY2025 · HL
Triglyceride-rich lipoproteins and abdominal aortic aneurysm growth and progression
$713,382Scott Michael Damrauer · University Of Pennsylvania · R01 · FY2025 · HL
Adherence Determinants in the Health Electronic Record Evaluation of Statins (ADHERES)
$713,373Fatima Rodriguez · Stanford University · R01 · FY2024 · HL
Multi-Omics and Chronic Kidney Disease: Correlation with Histology
$713,017Morgan Erika Grams · New York University School Of Medicine · R01 · FY2023 · DK
Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors
$712,969Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Clinical translation of targeted intracoronary imaging for inflammatory activity
$712,744Guillermo J. Tearney · Massachusetts General Hospital · R01 · FY2024 · HL
Platelet Expression of FcgammaRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
$712,730David Sigmund Liebeskind · University Of California Los Angeles · R01 · FY2022 · NS
Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH
$712,685Laney K Jones · Geisinger Clinic · R01 · FY2021 · HL
Targeted Molecular Probes for Atherosclerosis Imaging and Therapy
$712,545Yongjian Liu · Washington University · R35 · FY2024 · HL
Red blood cell released ATP in disturbed blood flow-initiated site specific vascular inflammation and atherosclerosis
$712,513Pingnian He · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2019 · HL
Obstructive sleep apnea, the microbiome and cardiovascular disease
$712,492Gabriel G Haddad · University Of California, San Diego · R01 · FY2025 · HL
VLDL and LDL Particle Types as CHD Risk Factors
$712,492Harvard University (Sch Of Public Hlth) · R01 · FY2005 · HL
Immune, hormonal, and muscle mitochondrial determinants of recovery in Acute Respiratory Distress Syndrome survivors
$712,421Matthew R Baldwin · Columbia University Health Sciences · R01 · FY2024 · HL